BlackRock Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.48M | Sell |
88,952
-48,498
| -35% | -$809K | ﹤0.01% | 1613 |
|
|
2016
Q3 | $2.83M | Buy |
137,450
+803
| +0.6% | +$16.5K | ﹤0.01% | 1291 |
|
|
2016
Q2 | $4.18M | Buy |
136,647
+1,839
| +1% | +$56.3K | ﹤0.01% | 1146 |
|
|
2016
Q1 | $5.05M | Buy |
134,808
+5,152
| +4% | +$193K | 0.01% | 1071 |
|
|
2015
Q4 | $5.6M | Buy |
129,656
+23,171
| +22% | +$1M | 0.01% | 1051 |
|
|
2015
Q3 | $3.99M | Buy |
106,485
+7,596
| +8% | +$285K | ﹤0.01% | 1155 |
|
|
2015
Q2 | $3.36M | Buy |
98,889
+87,999
| +808% | +$2.99M | ﹤0.01% | 1069 |
|
|
2015
Q1 | $386K | Sell |
10,890
-6,804
| -38% | -$241K | ﹤0.01% | 2245 |
|
|
2014
Q4 | $603K | Sell |
17,694
-3,819
| -18% | -$130K | ﹤0.01% | 1832 |
|
|
2014
Q3 | $830K | Sell |
21,513
-43,619
| -67% | -$1.68M | ﹤0.01% | 1531 |
|
|
2014
Q2 | $2.54M | Sell |
65,132
-1,901,809
| -97% | -$74M | ﹤0.01% | 1091 |
|
|
2014
Q1 | $67.3M | Buy |
1,966,941
+79,355
| +4% | +$2.71M | 0.07% | 281 |
|
|
2013
Q4 | $39.6M | Buy |
1,887,586
+52,941
| +3% | +$1.11M | 0.04% | 381 |
|
|
2013
Q3 | $43.1M | Buy |
1,834,645
+218,102
| +13% | +$5.13M | 0.04% | 348 |
|
|
2013
Q2 | $43.4M | Buy |
+1,616,543
| New | +$43.4M | 0.05% | 342 |
|